RESUMEN
We present a magnetic phase diagram of rare-earth pyrochlore Yb_{2}Ti_{2}O_{7} in a ⟨111⟩ magnetic field. Using heat capacity, magnetization, and neutron scattering data, we show an unusual field dependence of a first-order phase boundary, wherein a small applied field increases the ordering temperature. The zero-field ground state has ferromagnetic domains, while the spins polarize along ⟨111⟩ above 0.65 T. A classical Monte Carlo analysis of published Hamiltonians does account for the critical field in the low T limit. However, this analysis fails to account for the large bulge in the reentrant phase diagram, suggesting that either long-range interactions or quantum fluctuations govern low field properties.
RESUMEN
We report an experimental and computational study of the Hall effect in Mn(1-x)Fe(x)Si, as complemented by measurements in Mn(1-x)Co(x)Si, when helimagnetic order is suppressed under substitutional doping. For small x the anomalous Hall effect (AHE) and the topological Hall effect (THE) change sign. Under larger doping the AHE remains small and consistent with the magnetization, while the THE grows by over a factor of 10. Both the sign and the magnitude of the AHE and the THE are in excellent agreement with calculations based on density functional theory. Our study provides the long-sought material-specific microscopic justification that, while the AHE is due to the reciprocal-space Berry curvature, the THE originates in real-space Berry phases.
RESUMEN
For the application of the BNCT for the excorporal treatment of organs at the TRIGA Mainz, the basic characteristics of the radiation field in the thermal column as beam geometry, neutron and gamma ray energies, angular distributions, neutron flux, as well as absorbed gamma and neutron doses must be determined in a reproducible way. To determine the mixed irradiation field thermoluminescence detectors (TLD) made of CaF(2):Tm with a newly developed energy-compensation filter system and LiF:Mg,Ti materials with different (6)Li concentrations and different thicknesses as well as thin gold foils were used.
Asunto(s)
Terapia por Captura de Neutrón de Boro/instrumentación , Reactores Nucleares , Boro/uso terapéutico , Terapia por Captura de Neutrón de Boro/estadística & datos numéricos , Transferencia de Energía , Neutrones Rápidos/uso terapéutico , Fluoruros , Rayos gamma/uso terapéutico , Alemania , Humanos , Técnicas In Vitro , Isótopos/uso terapéutico , Compuestos de Litio , Neoplasias Hepáticas/radioterapia , Neoplasias Hepáticas/secundario , Neoplasias Hepáticas/cirugía , Trasplante de Hígado , Reactores Nucleares/estadística & datos numéricos , Fantasmas de Imagen , Fármacos Sensibilizantes a Radiaciones/uso terapéutico , Planificación de la Radioterapia Asistida por Computador/estadística & datos numéricos , Dosimetría Termoluminiscente , Trasplante AutólogoRESUMEN
Rapidly involuting congenital hemangioma (RICH) is a rare vascular lesion, identified in 1996, of elective localization in the dermal-hypodermic tissue. Its name comes from its particular natural course: it is fully developed at birth and then completely involutes, usually in the first year. We present a case of a RICH of the scalp discovered with a screening ultrasonography in the 31st week of gestation. We list the differential diagnoses. After birth, positive diagnosis lies preferably on pathology examination of a biopsy specimen in order to eliminate the hypothesis of a less favorable vascular lesion, teratoma or malignant tumor.
Asunto(s)
Hemangioma/congénito , Neoplasias Cutáneas/congénito , Adulto , Diagnóstico Diferencial , Femenino , Hemangioma/diagnóstico , Hemangioma/patología , Hemangioma/cirugía , Humanos , Recién Nacido , Masculino , Embarazo , Resultado del Embarazo , Neoplasias Cutáneas/diagnóstico , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/cirugía , Resultado del Tratamiento , Ultrasonografía PrenatalRESUMEN
In order to validate the in vivo micronucleus test in mouse splenocytes using the cytokinesis block method, 14 compounds with various mechanisms of action were tested: three direct alkylating agents (mitomycin C, ethylnitrosourea, beta-propiolactone), seven indirect alkylating agents (cyclophosphamide, benzo[a]pyrene, diethylnitrosamine, dimethylnitrosamine, 4-aminophenol, 4-aminobiphenyl, 1,1-dimethylhydrazine), two intercalating agents (acridine orange, ethidium bromide) and two spindle poisons (vincristine, colchicine). Male mice were dosed once with the compound, and spleen samples were taken 2 or 14 days after treatment. A significant increase in the binucleated micronucleated splenocyte rate was observed with all the alkylating and intercalating agents at at least one sampling time. In contrast, no increase in the binucleated micronucleated splenocyte rate was observed with the spindle poisons. In conclusion, under these experimental conditions, this in vivo test seems appropriate for the detection of clastogenic compounds including compounds that cannot be detected in the bone marrow micronucleus test. The limit of this test, as expected, is the lack of detection of aneugenic compounds.